Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanisms

Am J Reprod Immunol. 2012 Sep;68(3):233-7. doi: 10.1111/j.1600-0897.2012.01164.x. Epub 2012 Jun 4.

Abstract

Problem: Uterine innate immunity remains poorly characterized, and while endometrial endothelial cells are known to express Toll-like receptors (TLRs), little is known about their function in these cells. The present study evaluated the effect of Gram-negative bacterial lipopolysaccharide (LPS) on human endometrial endothelial cell (HEECs) cytokine secretion and tissue factor expression, and the role of TLR-4 in these responses.

Methods: Human endometrial endothelial cells were treated with or without LPS ± LPS-RS, a TLR-4 antagonist, via the binding of MD-2. After 24 hr, cell-free supernatants were evaluated for cytokines by multiplex analysis and cell lysates were analyzed for tissue factor expression by Western blot.

Results: Treatment of HEECs with LPS significantly upregulated the secretion of IL-6, IL-8, and G-CSF, and this was prevented by LPS-RS. LPS also induced tissue factor expression by the HEECs; however, this was unaffected by LPS-RS.

Conclusion: These findings suggest that TLR-4 is functional in HEECs and its activation by bacterial LPS induces a specific cytokine/chemokine response. However, bacterial LPS also induced tissue factor expression in what seemed to be a TLR-4-independent fashion, suggesting that this bacterial component can act on the HEECs through TLR-4-dependent and TLR-4-independent pathways. These findings indicate that endometrial endothelial cells may play an active role in uterine innate immunity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Endometrium / cytology
  • Endometrium / drug effects*
  • Endometrium / immunology
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / immunology
  • Female
  • Granulocyte Colony-Stimulating Factor / genetics
  • Granulocyte Colony-Stimulating Factor / immunology
  • Humans
  • Immunity, Innate / drug effects*
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology
  • Interleukin-8 / genetics
  • Interleukin-8 / immunology
  • Lipopolysaccharides / pharmacology*
  • Lymphocyte Antigen 96 / genetics
  • Lymphocyte Antigen 96 / immunology
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Thromboplastin / genetics
  • Thromboplastin / immunology
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / immunology*
  • Up-Regulation / drug effects
  • Up-Regulation / immunology

Substances

  • CXCL8 protein, human
  • IL6 protein, human
  • Interleukin-6
  • Interleukin-8
  • LY96 protein, human
  • Lipopolysaccharides
  • Lymphocyte Antigen 96
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • Granulocyte Colony-Stimulating Factor
  • Thromboplastin